Therefore, we suggested that Notch1 may mediate glioma TMZ resistance, and T+A@Glu‐NPs can downregulate Notch1 by degrading BRD4 protein, thereby reversing glioma TMZ resistance. This evidence concerns the gene BRD4 and central nervous system cancer.